These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22302208)

  • 21. Fluvastatin inhibits high glucose-induced nuclear factor kappa B activation in renal tubular epithelial cells.
    Gao P; Wu X; Shui H; Jia R
    J Nephrol; 2013; 26(2):289-96. PubMed ID: 22641573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inhibition of nuclear factor kappa B attenuates multiple organ injury following ruptured abdominal aortic aneurysm: an experiment with rats].
    Yang J; Hu XH; Liu CW; Zhang ZS; Li TM; Yang DH; Zhang Q
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):237-41. PubMed ID: 16677502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin II receptor blockade blocker pre-treatment largely prevents injury from gradual renal ablation in rats.
    Park HW; Kim Y; Kim KH; Jeong HJ; Shin MH; Rozen S; Mauer M
    J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):110-7. PubMed ID: 17907098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ezetimibe alone or in combination with pitavastatin prevents kidney dysfunction in 5/6 nephrectomized rats fed high-cholesterol.
    Mori Y; Hirano T
    Metabolism; 2012 Mar; 61(3):379-88. PubMed ID: 21868047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tong-xin-luo capsule inhibits left ventricular remodeling in spontaneously hypertensive rats by enhancing PPAR-gamma expression and suppressing NF-kappaB activity.
    Bu PL; Zhao XQ; Wang LL; Zhao YX; Li CB; Zhang Y
    Chin Med J (Engl); 2008 Jan; 121(2):147-54. PubMed ID: 18272042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction.
    Vaziri ND; Bai Y; Ni Z; Quiroz Y; Pandian R; Rodriguez-Iturbe B
    J Pharmacol Exp Ther; 2007 Oct; 323(1):85-93. PubMed ID: 17636006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enalapril reduces the expression of nuclear factor-kappaB and c-Jun N-terminal kinase in the renal cortices of five-sixths-nephrectomized rats.
    Costa JC; Costa RS; Silva CG; Coimbra TM
    Am J Nephrol; 2006; 26(3):281-6. PubMed ID: 16772709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-kappaB-dependent pathway in rat preadipocytes.
    Tsuchiya K; Yoshimoto T; Hirono Y; Tateno T; Sugiyama T; Hirata Y
    Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E771-8. PubMed ID: 16705055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardioprotective effects of low-dose combination therapy with a statin and an angiotensin receptor blocker in a rat myocardial infarction model.
    Sohma R; Inoue T; Abe S; Taguchi I; Kikuchi M; Toyoda S; Arikawa T; Hikichi Y; Sanada S; Asanuma H; Kitakaze M; Node K
    J Cardiol; 2012 Jan; 59(1):91-6. PubMed ID: 21925839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis.
    Naito T; Ma LJ; Yang H; Zuo Y; Tang Y; Han JY; Kon V; Fogo AB
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F683-91. PubMed ID: 20042458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different protective actions of losartan and tempol on the renal inflammatory response to acute sodium overload.
    Rosón MI; Della Penna SL; Cao G; Gorzalczany S; Pandolfo M; Toblli JE; Fernández BE
    J Cell Physiol; 2010 Jul; 224(1):41-8. PubMed ID: 20232302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1.
    Kang BY; Mehta JL
    J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):283-91. PubMed ID: 19724024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-β/Smad and NF-κB signaling pathway in 5/6 nephrectomized rats.
    Wang DT; Huang RH; Cheng X; Zhang ZH; Yang YJ; Lin X
    Int Immunopharmacol; 2015 May; 26(1):4-12. PubMed ID: 25744602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effects of angiotensin-(1-7) administrated with an angiotensin-receptor blocker in a rat model of chronic kidney disease.
    Xu C; Ding W; Zhang M; Gu Y
    Nephrology (Carlton); 2013 Dec; 18(12):761-9. PubMed ID: 23901805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin AT1-receptor inhibition exacerbates renal injury resulting from partial unilateral ureteral obstruction in the neonatal rat.
    Coleman CM; Minor JJ; Burt LE; Thornhill BA; Forbes MS; Chevalier RL
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F262-8. PubMed ID: 17442727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats.
    Song J; Meng L; Li S; Qu L; Li X
    Vascul Pharmacol; 2009; 50(5-6):185-93. PubMed ID: 19563735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II receptor blocker pretreatment of rats undergoing sudden renal ablation.
    Park HW; Kim Y; Kim KH; Rozen S; Najafian B; Mauer M
    Nephrol Dial Transplant; 2012 Jan; 27(1):107-14. PubMed ID: 21633100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats].
    Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):53-61. PubMed ID: 15782494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.